(Official FDA prescribing information for the T2D indication: confirms same six dose strengths 2.5, 5, 7.5, 10, 12.5, 15mg and identical titration interval as Zepbound.) Jastreboff AM, Aronne LJ, Ahmad NN, et al
Doctors usually start patients at 0.25 mg once weekly for 4 weeks and then the dose is gradually increased every 4 weeks until the maximum dose of 2.4 mg once a week is reached
Tirzepatide may cause slightly stronger digestive symptoms early due to its dual-hormone action, while semaglutide may feel milder for some patients at first
Requires multiple syringe draws or a larger syringe
Additionally, it enhances insulin secretion in response to meals while suppressing glucagon release, which helps regulate blood sugar levels and may indirectly support weight management